August 1, 2007

For Immediate Release

Over 500 Medtech Startup Companies Identified

FOOTHILL RANCH, CA —  Over 500 companies represented in the Medtech Startup Companies Database from MedMarket Diligence comprise a robust range of new technologies --- and offer many opportunities for technology licensing, joint venture, investment and acquisition.  Technologies under development include medical devices, diagnostics, drugs, biomaterials and others.

Needs served by this database:

Below is a distribution of companies by clinical/technology category (note, multiple categories possible per company):

 

Clinical/Technology
Category		 # Companies
arrhythmia 11
biomaterials 37
biotechnology 40
bloodorgantissue 28
cardio_dx 21
cardio_tx 95
critical_care 3
dental_oral 4
diagnostics 20
drug_delivery 18
drug_discovery 11
dx_imaging 27
interv_rad 46
minimally_invasive 55
neuro_neurosurg 24
oncology 43
ophthalmology 10
orthomusculoskeletal 72
patient_monitor 10
pharma 13
surgery 96
urogenital 16
wound 26
other 12

 

The MedMarket Diligence database of medtech startup companies is compiled and maintained through active research from multiple public domain and private sources, very often revealing companies previously kept "under the radar".  The database is described, with screenshots, here. For additional details, contact Patrick Driscoll at 949-859-3401 or patrick-at-mediligence-dot-com.

About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated Reports on technology markets.  For additional details, contact Patrick Driscoll at email or call 949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.